Germfree

Next week, May 7-11, catch #TeamGermfree at the American Society of Gene & Cell Therapy's 27th Annual Meeting! ✈️👏 Stop by booth #1950 to explore Germfree's cutting-edge cGMP-compliant facility and equipment solutions. Can't be there in person? Book a discovery call with a Germfree expert today! ➡️ https://hubs.ly/Q02vX1NF0 #ASGCT #CellandGeneTherapy #cGMP #Cleanrooms

Have you seen Germfree and Phacilitate's panel series on decentralized manufacturing? 🤔 Check out panel 5, where Sean Bartholomew (Biopharma Applications Engineer, Germfree) and Grayson Heller (COO, cGMPnow) unravel the complexities of decentralized cell therapy manufacturing. 💡 Discover why a focus on identical, cloned processes and a copy-paste model for multiple locations are crucial for success in decentralized manufacturing. 👀➡️ https://hubs.ly/Q02vKQGz0 #Decentralized #CellTherapy #GeneTherapy #PointofCare #ATW24

Mark your calendars for May 6th! #TeamGermfree is headed to Boston for Global Manufacturing Strategies' CGTTalk, where we will be sharing our tips for success when developing decentralized manufacturing solutions. 💡 Plus, gain insights into how Germfree's facility and equipment solutions can revolutionize your cell and gene therapy processes. 👀 Can't be there in person? Book a meeting with a Germfree expert today! ➡️ https://hubs.ly/Q02vx1Vg0 #CGTTalk2024 #CGT #CellandGeneTherapies #Decentralized #cGMP

The rapidly evolving field of cell and gene therapies presents unique challenges and requirements, necessitating specialized cleanroom design. If you're contemplating developing cell and gene therapy products, it's essential to establish a cleanroom environment specifically tailored for their manufacturing. 💡 Learn the top 20 considerations for the design of cell and gene therapy cleanrooms here. ➡️ https://hubs.ly/Q02tWt_G0 #CellandGeneTherapy #Cleanrooms #Biopharma #cGMP

Successfully implementing IV workflow software requires great hardware. Sourcing the right peripherals requires a lot of time, resources, and capital. ✔️ Best case scenario: You have a cluttered hood with cameras, touchscreens, keyboards, a scanner, a printer, and possibly a scale. ❌ Worst case scenario: These are outside of the hood, forcing your technicians to use bad aseptic technique. What if all these things were BUILT-IN to the hood? 🤔 Discover Smarthood™ by Germfree, your all-in-one IV workflow solution. 💪➡️ https://hubs.ly/Q02tFKdm0 #Smarthood #Healthcare #Innovation #IVWorkflow

Day 1 of INTERPHEX Global 2024 is underway! 👏 Meet with #TeamGermfree at booth # 2961 to discover how Germfree's cleanroom and equipment solutions provide seamless operational scalability for your important biopharmaceutical processes. 👀 Can't be there in person? Book a meeting with one of our experts today! ➡️ https://hubs.ly/Q02t0S7T0 #Interphex2024

Take a tour of our recently delivered 40-ft Mobile CL-2 Laboratory! 🤩 Equipped with an innovative hydraulic slide-out, this facility offers expanded working space for enhanced functionality. 💪 Discover how our team's design and engineering efforts have created a versatile solution for various processes and applications. 👀➡️ https://hubs.ly/Q02sJyb70 #Innovation #CL2 #Containment #MobileLab

📢 Attention industry experts! 💪 Germfree and AST are seeking your input on aseptic processing isolators and fill-finish equipment. Tell us, what factors influence your choice of aseptic processing isolators and fill-finish equipment vendors? 🤔⬇ #ASTxGermfree #Isolators #IsolatorTechnology

April 16th - 18th, join #TeamGermfree in New York City for INTERPHEX 2024! 👏🗽Connect with us during the event to discover how our cleanroom and equipment solutions can optimize your critical operations. 💡 Can't be there in person? Book a meeting with one of our experts today! ➡️ https://hubs.ly/Q02sr_XK0 #INTERPHEXGlobal #INTERPHEX2024

📢 EXCITING NEWS! Germfree and Orgenesis Inc. Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility. 🤝 By combining Germfree’s expertise in designing, manufacturing, and maintaining advanced manufacturing facility environments with Orgenesis’ cutting-edge processes and analytical development capabilities, the partnership seeks to significantly reduce the production costs of cell and gene therapy products. The ultimate goal is to enable broader adoption of life-saving treatments. ✔️ Vered Caplan, CEO of Orgenesis, stated, “Under the agreement, Orgenesis and Germfree will join forces to co-market Orgenesis’ decentralized Octomera service platform, and its Octomera Mobile Processing Units and Labs (OMPULs™) globally. The partnership marks a significant milestone in the bio-manufacturing industry, as the industry begins to pivot to the paradigm-shifting distributed processing of cell and gene therapies (CGTs). Germfree will be marketing, manufacturing, and servicing OMPULs as part of its modular cleanroom fleet, enabling Orgenesis to focus on its therapeutic pipeline with an emphasis on immuno-oncology. We are delighted to work with Germfree to meet the growing demand for our platform.” ⚛️ Kevin Kyle, CEO of Germfree, shared his insights on the collaboration, “Our strategic partnership with Orgenesis is a cornerstone in the continuation of our mission to advance healthcare solutions globally. By integrating Germfree’s modular cleanroom technology with Orgenesis’ innovative cell and gene therapy programs, we are setting a new benchmark for efficiency and accessibility in the treatment of life-threatening conditions. This collaboration is not just about enhancing production capabilities; it's about creating a paradigm shift in how cell therapies are developed, produced, and delivered to those in dire need. Together, we are building the foundation for a future where advanced medical treatments are no longer a privilege, but a right, accessible to everyone, everywhere.” 💪 Germfree is continuing to invest in cleanroom design and manufacturing solutions and is committed to providing innovative solutions, with the goal of improving patient access to critical medicines. Germfree is backed by the healthcare growth equity investor, EW Healthcare Partners.  Read the full press release. ➡️ https://hubs.ly/Q02sshZl0 #BreakingNews #PressRelease #Orgenesis #Germfree #Innovation #CGTInnovation #CellandGeneTherapy #DecentralizedManufacturing